Journal of the American Academy of Child & Adolescent Psychiatry
New ResearchNational Comorbidity Survey Replication Adolescent Supplement (NCS-A): II. Overview and Design
Section snippets
Fieldwork Organization and Procedures
The NCS-A fieldwork was performed by the same professional national field interview staff from the Survey Research Center (SRC) at the University of Michigan that performed the NCS-R. There were 197 interviewers supervised by a team of 18 experienced regional supervisors. A study manager located at the central SRC facility in Michigan oversaw the work of the supervisors and their staff. Upon making in-person contact, the interviewer answered questions before obtaining written informed consent
Sample Disposition
The NCS-A sample disposition is reported in Table 1. The overall adolescent response rate was 75.6%, for a total of 10,148 completed interviews. This is made up of response rates of 85.9% (n = 904) in the household sample, 81.8% (n = 8,912) in the unblinded school sample, and 22.3% (n = 332) in the blinded school sample. Nonresponse was largely due to refusal (21.3%), which, in the household and unblinded school samples, came largely from parents rather than adolescents (72.3% and 81.0%,
Discussion
This article presented an overview of the NCS-A survey design and field procedures. The design allowed us to gather data from a nationally representative sample of adolescents and schools. An important limitation of the NCS-A is the relatively low response rate of schools in the school sample, but we were able to show in analyses reported here that this seems not to have introduced bias into estimates of the prevalence of mental disorders or estimates of treatment rates. Nonetheless, because of
References (7)
- et al.
The National Comorbidity Survey Replication Adolescent Supplement (NCS-A): I. Background and measures
J Am Acad Child Adolesc Psychiatry
(2009) - et al.
The National Comorbidity Survey Replication Adolescent Supplement (NCS-A): III. Concordance of DSM-IV/CIDI Diagnoses with Clinical Reassessments
J Am Acad Child Adolesc Psychiatry
(2009) - et al.
The National Comorbidity Survey Replication (NCS-R): background and aims
Int J Methods Psychiatr Res
(2004)
Cited by (184)
Effects of prenatal cannabis exposure on developmental trajectory of cognitive ability and brain volumes in the adolescent brain cognitive development (ABCD) study
2023, Developmental Cognitive NeuroscienceDimensions of Early Adversity and Sexual Behavior in a US Population-Based Adolescent Sample
2023, Journal of Adolescent HealthAn Overview of Epidemiology in Clinical Psychology
2022, Comprehensive Clinical Psychology, Second EditionAssociations of Sociodemographic Factors and Psychiatric Disorders With Type of School-Based Mental Health Services Received by Youth
2020, Journal of Adolescent Health
The National Comorbidity Survey Replication Adolescent Supplement (NCS-A) is supported by the National Institute of Mental Health (NIMH; Grant U01-MH60220) with supplemental support from the National Institute on Drug Abuse, the Substance Abuse and Mental Health Services Administration, the Robert Wood Johnson Foundation (Grant 044780), and the John W. Alden Trust. The work of Dr. Merikangas and her staff on the NCS-A is supported by the NIMH Intramural Research Program, whereas the work of Dr. Zaslavsky and his staff on the validity of the NCS-A measures is supported by NIMH Grant R01-MH66627. The views and opinions expressed in this article are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or U.S. Government. A complete list of NCS-A publications can be found at http://www.hcp.med.harvard.edu/ncs.
The NCS-A is performed in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the staff of the WMH Data Collection and Data Analysis Coordination Centers for assistance with instrumentation, fieldwork, and consultation on data analysis. The WMH Data Coordination Centers have received support from NIMH (Grants R01-MH070884, R13-MH066849, R01-MH069864, and R01-MH077883), NIDA (Grant R01-DA016558), the Fogarty International Center of the National Institutes of Health (FIRCA R03-TW006481), the John D. and Catherine T MacArthur Foundation, the Pfizer Foundation, and the Pan American Health Organization. The WMH Data Coordination Centers have also received unrestricted educational grants from Astra Zeneca, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Ortho-McNeil, Pfizer, Sanofi-Aventis, and Wyeth. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/.
The authors thank Steven Heeringa, Ph.D., and Alan Zaslavsky, Ph.D., for statistical expertise.
This article is the subject of an editorial by Dr. Peter Szatmari in this issue.